Article
Consensus on the Development of Vaccines against Naturally Acquired Melioidosis
29 Apr 2015
Abstract excerpt
Several candidates for a vaccine against Burkholderia pseudomallei, the causal bacterium of melioidosis, have been developed, and a rational approach is now needed to select and advance candidates for testing in relevant nonhuman primate models and in human clinical trials. Development of such a vaccine was the topic of a meeting in the United Kingdom in March 2014 attended by international candidate vaccine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
